Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Using a rat model of ischemia/reperfusion injury, we demonstrate here that HGF is cardioprotective due to its antiapoptotic effect on cardiomyocytes. Following transient myocardial ischemia and reperfusion, c-Met/HGF receptor expression rapidly increased in the ischemic myocardium, an event accompanied by a dramatic increase in plasma HGF levels in the infarcted rats. When endogenous HGF was neutralized with a specific antibody, the number of myocyte cell deaths increased markedly, the infarct area expanded, and the mortality increased to 50%, as compared with a control group in which there was no mortality. Plasma from the myocardial infarcted rats had cardioprotective effects on primary cultured cardiomyocytes, but these effects were significantly diminished by neutralizing HGF. In contrast, recombinant HGF administration reduced the size of infarct area and improved cardiac function by suppressing apoptosis in cardiomyocytes. HGF rapidly augmented Bcl-xL expression in injured cardiomyocytes both in vitro and in vivo. As apoptosis of cardiomyocytes is one of the major contributors to the pathogenesis in subjects with ischemia/reperfusion injury, prevention of apoptosis may prove to be a reasonable therapeutic strategy. Supplements of HGF, an endogenous cardioprotective factor, may be found clinically suitable in treating subjects with myocardial infarction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Higgins, S. M. F., Macken, A. P., Cullen, W., Saunders, J., Dunne, C. P., & O’Gorman, C. S. (2013) · PubMed · doi:10.34961/9953 · Cited by 4,806
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M.-L., Kmiecik, T. E., Vande Woude, G. F., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1846706 · Cited by 2,236
Molecular cloning and expression of human hepatocyte growth factor
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., & Shimizu, S. (1989) · Nature · doi:10.1038/342440a0 · Cited by 2,157
Self-citationApoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673
The global burden of disease, 1990–2020
Lopez, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,614
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
Gottlieb, R. A., Burleson, K. O., Kloner, R. A., Babior, B. M., & Engler, R. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117504 · Cited by 1,441
Nakamura, T., Nawa, K., & Ichihara, A. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91253-1 · Cited by 1,134
Self-citationFujio, Y., Nguyen, T., Wencker, D., Kitsis, R. N., & Walsh, K. (2000) · Circulation · doi:10.1161/01.cir.101.6.660 · Cited by 847
Apoptosis in Ischemic and Reperfused Rat Myocardium
Fliss, H., & Gattinger, D. (1996) · Circulation Research · doi:10.1161/01.res.79.5.949 · Cited by 797
Cited by
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Targeting MET in cancer: rationale and progress
Gherardi, E., Birchmeier, W., Birchmeier, C., & Woude, G. V. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3205 · Cited by 1,423
Mechanisms of Cell Death in Oxidative Stress
Ryter, S. W., Kim, H. P., Hoetzel, A., Park, J. W., Nakahira, K., Wang, X., & Choi, A. M. K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.9.49 · Cited by 1,261
Hausenloy, D. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.09.024 · Cited by 996
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
URBICH, C., AICHER, A., HEESCHEN, C., DERNBACH, E., HOFMANN, W., ZEIHER, A., & DIMMELER, S. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.07.003 · Cited by 741
Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Uematsu, M., Ohgushi, H., Yamagishi, M., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.500447 · Cited by 669
NAKAMURA, T., & MIZUNO, S. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.588 · Cited by 547
Self-citationNovel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Eder, J. P., Vande Woude, G. F., Boerner, S. A., & LoRusso, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1306 · Cited by 522
Met provides essential signals for liver regeneration
Borowiak, M., Garratt, A. N., Wüstefeld, T., Strehle, M., Trautwein, C., & Birchmeier, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403412101 · Cited by 497
GATA transcription factors in the developing and adult heart
PIKKARAINEN, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.025 · Cited by 416
Understanding, recognizing, and managing toxicities of targeted anticancer therapies
Dy, G. K., & Adjei, A. A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21184 · Cited by 331
c-Met is essential for wound healing in the skin
Chmielowiec, J., Borowiak, M., Morkel, M., Stradal, T., Munz, B., Werner, S., Wehland, J., Birchmeier, C., & Birchmeier, W. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701086 · Cited by 317
Ruvinov, E., & Cohen, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.021 · Cited by 303
Therapeutic angiogenesis for critical limb ischaemia
Annex, B. H. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.70 · Cited by 298
MET: a promising anticancer therapeutic target
Peters, S., & Adjei, A. A. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.71 · Cited by 280
Liu, X., Wang, Q., Yang, G., Marando, C., Koblish, H. K., Hall, L. M., Fridman, J. S., Behshad, E., Wynn, R., Li, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1157 · Cited by 265
The MET receptor tyrosine kinase in invasion and metastasis
Benvenuti, S., & Comoglio, P. M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21183 · Cited by 253
From Tpr-Met to Met, tumorigenesis and tubes
Peschard, P., & Park, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210201 · Cited by 180
“, 2006), consistent with a prominent role for Met and HGF/SF in tissue repair in the adult (Michalopoulos and DeFrances, 1997; Nakamura et al., 2000; Matsumoto and Nakamura, 2001).”
BackgroundInfluentialMizuno, S., Matsumoto, K., Li, M.-Y., & Nakamura, T. (2005) · The FASEB Journal · doi:10.1096/fj.04-1535fje · Cited by 177
“For a variety of cells, HGF has anti-apoptotic action (31, 32), whereas HGF has the potential to stimulate apoptotic cell death in some distinct types of cells, including transformed or neoplastic cells (33), indicating that HGF biologically regulates cell survival in a cell type-dependent manner.”
BackgroundSelf-citationStem cell-inspired secretome-rich injectable hydrogel to repair injured cardiac tissue
Waters, R., Alam, P., Pacelli, S., Chakravarti, A. R., Ahmed, R. P. H., & Paul, A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.12.025 · Cited by 168
Park, B.-W., Jung, S.-H., Das, S., Lee, S. M., Park, J.-H., Kim, H., Hwang, J.-W., Lee, S., Kim, H.-J., Kim, H.-Y., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay6994 · Cited by 133
“We chose HGF as a major inducer for in vivo priming since HGF is a renowned pleiotropic factor that is involved in multiple biological activities, such as cell proliferation and survival, angiogenesis, and antifibrotic and antiapoptotic activities ( 21 – 24 ).”
Sullivan, K. E., Quinn, K. P., Tang, K. M., Georgakoudi, I., & Black, L. D. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt403 · Cited by 117
“24 hours later, media was replaced with a 50:50 mixture of conditioned media and IMDM [45].”
BackgroundInfluentialFutamatsu, H., Suzuki, J.-I., Mizuno, S., Koga, N., Adachi, S., Kosuge, H., Maejima, Y., Hirao, K., Nakamura, T., & Isobe, M. (2005) · Circulation Research · doi:10.1161/01.res.0000163016.52653.2e · Cited by 82
Self-citationHepatocyte growth factor promotes the number of PSD-95 clusters in young hippocampal neurons
Nakano, M., Takagi, N., Takagi, K., Funakoshi, H., Matsumoto, K., Nakamura, T., & Takeo, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.06.007 · Cited by 22
Self-citationEngineering the cardiac tissue microenvironment
Ronan, G., Bahcecioglu, G., Aliyev, N., & Zorlutuna, P. (2024) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ad0ea7 · Cited by 4
Metadata
- Authors
- Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-12-15
- Volume
- 106
- Issue
- 12
- Pages
- 1511-1519
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2147135453
- Cited by
- 434
- References
- 49
- FWCI
- 8.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.